Alison Highlander - Silk Road Vice Resources

SILKDelisted Stock  USD 27.49  0.00  0.00%   

Executive

Alison Highlander is Vice Resources of Silk Road Medical
Phone408 720 9002
Webhttps://silkroadmed.com

Silk Road Management Efficiency

The company has return on total asset (ROA) of (0.1411) % which means that it has lost $0.1411 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.3645) %, meaning that it created substantial loss on money invested by shareholders. Silk Road's management efficiency ratios could be used to measure how well Silk Road manages its routine affairs as well as how well it operates its assets and liabilities.
Silk Road Medical currently holds 84.63 M in liabilities with Debt to Equity (D/E) ratio of 1.37, which is about average as compared to similar companies. Silk Road Medical has a current ratio of 6.78, suggesting that it is liquid enough and is able to pay its financial obligations when due. Note, when we think about Silk Road's use of debt, we should always consider it together with its cash and equity.

Similar Executives

Showing other executives

EXECUTIVE Age

Mark AndersonTransMedics Group
N/A
Scot ElderTreace Medical Concepts
49
Michael DonovanAxogen Inc
59
Trui HebbelinckLivaNova PLC
52
Matthew LinkSight Sciences
Julie DeweyTreace Medical Concepts
63
Matthew BrinckmanParagon 28
N/A
Aimee EinsteinSi Bone
N/A
Roy FreemanRxsight
N/A
Manohar RahejaSight Sciences
N/A
Jrme ErathPulmonx Corp
N/A
Sean ScanlanTreace Medical Concepts
43
Lucas VitaleOrthofix Medical
47
Maria MartinezAxogen Inc
56
Paul KoehnInari Medical
62
Angela JDInari Medical
N/A
Jeremy JDSight Sciences
55
Mehul JoshiPulmonx Corp
64
Nicholas CorcoranTransMedics Group
42
Deanna WilkeLivaNova PLC
N/A
Jens KempAxogen Inc
N/A
Silk Road Medical, Inc. operates as a medical device company in the United States. The company was incorporated in 2007 and is headquartered in Sunnyvale, California. Silk Road operates under Medical Devices classification in the United States and is traded on NASDAQ Exchange. It employs 352 people. Silk Road Medical (SILK) is traded on NASDAQ Exchange in USA and employs 474 people.

Management Performance

Silk Road Medical Leadership Team

Elected by the shareholders, the Silk Road's board of directors comprises two types of representatives: Silk Road inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Silk. The board's role is to monitor Silk Road's management team and ensure that shareholders' interests are well served. Silk Road's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Silk Road's outside directors are responsible for providing unbiased perspectives on the board's policies.
Erica Rogers, President CEO, Director
Sumaira Macdonald, Chief Medical Officer
Mhairi Jones, VP Accounting
Sumaira MD, Executive Director
Kevin Ballinger, Chief Sec
Tammy Leitsinger, Compliance Affairs
Kevin Klemz, Chief EVP
Alison Highlander, Vice Resources
Jorge OHara, Business Marketing
Charles McKhann, Chief Officer
Richard Ruedy, Executive Vice President - Regulatory Affairs, Clinical Affairs & Quality Assurance
Lucas Buchanan, CFO COO
Lynn Lewis, Investors Officer
Andrew Davis, Chief Officer
Matthew McCarthy, Vice Marketing

Silk Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Silk Road a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis.
You can also try the Earnings Calls module to check upcoming earnings announcements updated hourly across public exchanges.

Other Consideration for investing in Silk Stock

If you are still planning to invest in Silk Road Medical check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Silk Road's history and understand the potential risks before investing.
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Stocks Directory
Find actively traded stocks across global markets
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.